Kai Blin

21.3k citations
49 papers · 13.2k · 8 hit papers · h-index 25

Impact in

  • Pharmacology top 0.02%
    • Microbial Natural Products and Biosynthesis
  • Biotechnology top 0.05%
    • Marine Sponges and Natural Products

Papers in

    • Genomics and Phylogenetic Studies 22
    • Plant biochemistry and biosynthesis 11
    • RNA and protein synthesis mechanisms 7
    • CRISPR and Genetic Engineering 6
    • Microbial Metabolic Engineering and Bioproduction 5
    • Microbial Natural Products and Biosynthesis 37

Kai Blin

45 papers receiving 13.1k citations

Kai Blin's Hit Papers

antiSMASH 7.0: new and improved predictions for detection, regulation, chemical structures and visualisation 2023 · 1.3k citations
1.3k0+5+10Years since publication50010001.5k2.0k

Peers

Kai Blin
Comparison fields: 5 of 134
  • Pharmacology 6.1k
  • Biotechnology 2.2k
  • Microbiology 146
  • Molecular Biology 8.6k
  • Plant Science 2.9k
Replace Tilmann Weber with:
Tilmann Weber Denmark
Marnix H. Medema Netherlands
Eriko Takano United Kingdom
Mervyn J. Bibb United Kingdom
Wolfgang Wohlleben Germany
Juan F. Martı́n Spain
Keith Chater United Kingdom
Nadine Ziemert Germany
Simon J. Shaw United States
Stefano Donadio Italy
Kai Blin relative to Tilmann Weber Denmark Tilmann Weber's profile →
Citations per field
00.5×1.5×
Tilmann Weber · 1×
Citations per year

Countries citing papers authored by Kai Blin

Since Specialization
Citations

This map shows the geographic impact of Kai Blin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Blin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Blin more than expected).

Fields of papers citing papers by Kai Blin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Blin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Blin. The network helps show where Kai Blin may publish in the future.

Co-authors

The 25 scholars most cited alongside Kai Blin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kai Blin Line = papers co-authored together Kai Blin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.

#Work
1
antiSMASH 5.0: updates to the secondary metabolite genome mining pipeline
Hit paper breakdown →
20192259
2
antiSMASH 6.0: improving cluster detection and comparison capabilities
Hit paper breakdown →
20211865
3
antiSMASH: rapid identification, annotation and analysis of secondary metabolite biosynthesis gene clusters in bacterial and fungal genome sequences
Hit paper breakdown →
20111571
4
antiSMASH 3.0—a comprehensive resource for the genome mining of biosynthetic gene clusters
Hit paper breakdown →
20151554
5
antiSMASH 7.0: new and improved predictions for detection, regulation, chemical structures and visualisation
Hit paper breakdown →
20231299
6
antiSMASH 4.0—improvements in chemistry prediction and gene cluster boundary identification
Hit paper breakdown →
2017959
7
antiSMASH 2.0—a versatile platform for genome mining of secondary metabolite producers
Hit paper breakdown →
2013681
8
NRPSpredictor2—a web server for predicting NRPS adenylation domain specificity
Hit paper breakdown →
2011509
9 2017339
10 2017236
11 2016196
12 2020158
13 2019157
14 2018153
15 2017148
16 2016143
17 2017142
18 2020139
19 2020105
20 2014102

About Kai Blin

Kai Blin is a scholar working on Molecular Biology, Pharmacology, Biotechnology, Computational Theory and Mathematics and Plant Science, having authored 49 papers that have together received 13.2k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (37 papers), Genomics and Phylogenetic Studies (22 papers), Plant biochemistry and biosynthesis (11 papers), RNA and protein synthesis mechanisms (7 papers), CRISPR and Genetic Engineering (6 papers), Computational Drug Discovery Methods (5 papers), Microbial Metabolic Engineering and Bioproduction (5 papers) and Marine Sponges and Natural Products (5 papers). The work is most often cited by research in Pharmacology (6.1k citations), Biotechnology (2.2k citations), Microbiology (146 citations), Molecular Biology (8.6k citations) and Plant Science (2.9k citations). Kai Blin has collaborated with scholars based in Denmark, Germany and Netherlands. Frequent co-authors include Tilmann Weber, Marnix H. Medema, Simon J. Shaw, Sang Yup Lee, Eriko Takano, Rainer Breitling, Michael A. Fischbach, Gilles P. van Wezel, Nadine Ziemert and Kat Steinke. Their work appears in journals such as Nucleic Acids Research, Synthetic and Systems Biotechnology, ACS Chemical Biology, PLoS ONE and Briefings in Bioinformatics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact